Literature DB >> 29301109

Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up Samples.

Deborah Lyon1, Natasha Lapteva1, Adrian P Gee2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29301109      PMCID: PMC5763145          DOI: 10.1016/j.ymthe.2017.12.003

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  12 in total

1.  Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?

Authors:  Adham S Bear; Richard A Morgan; Kenneth Cornetta; Carl H June; Gwendolyn Binder-Scholl; Mark E Dudley; Steven A Feldman; Steven A Rosenberg; Sheila A Shurtleff; Cliona M Rooney; Helen E Heslop; Gianpietro Dotti
Journal:  Mol Ther       Date:  2012-02       Impact factor: 11.454

2.  Clinical responses with T lymphocytes targeting malignancy-associated κ light chains.

Authors:  Carlos A Ramos; Barbara Savoldo; Vicky Torrano; Brandon Ballard; Huimin Zhang; Olga Dakhova; Enli Liu; George Carrum; Rammurti T Kamble; Adrian P Gee; Zhuyong Mei; Meng-Fen Wu; Hao Liu; Bambi Grilley; Cliona M Rooney; Malcolm K Brenner; Helen E Heslop; Gianpietro Dotti
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

3.  Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation.

Authors:  Xiaoou Zhou; Gianpietro Dotti; Robert A Krance; Caridad A Martinez; Swati Naik; Rammurti T Kamble; April G Durett; Olga Dakhova; Barbara Savoldo; Antonio Di Stasi; David M Spencer; Yu-Feng Lin; Hao Liu; Bambi J Grilley; Adrian P Gee; Cliona M Rooney; Helen E Heslop; Malcolm K Brenner
Journal:  Blood       Date:  2015-05-14       Impact factor: 22.113

4.  Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients.

Authors:  Katherine T Marcucci; Julie K Jadlowsky; Wei-Ting Hwang; Megan Suhoski-Davis; Vanessa E Gonzalez; Irina Kulikovskaya; Minnal Gupta; Simon F Lacey; Gabriela Plesa; Anne Chew; J Joseph Melenhorst; Bruce L Levine; Carl H June
Journal:  Mol Ther       Date:  2017-10-20       Impact factor: 11.454

5.  Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.

Authors:  Kenneth Cornetta; Lisa Duffy; Cameron J Turtle; Michael Jensen; Stephen Forman; Gwendolyn Binder-Scholl; Terry Fry; Anne Chew; David G Maloney; Carl H June
Journal:  Mol Ther       Date:  2017-09-12       Impact factor: 11.454

6.  CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.

Authors:  Andras Heczey; Chrystal U Louis; Barbara Savoldo; Olga Dakhova; April Durett; Bambi Grilley; Hao Liu; Mengfeng F Wu; Zhuyong Mei; Adrian Gee; Birju Mehta; Huimin Zhang; Nadia Mahmood; Haruko Tashiro; Helen E Heslop; Gianpietro Dotti; Cliona M Rooney; Malcolm K Brenner
Journal:  Mol Ther       Date:  2017-06-09       Impact factor: 11.454

7.  Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.

Authors:  Nabil Ahmed; Vita S Brawley; Meenakshi Hegde; Catherine Robertson; Alexia Ghazi; Claudia Gerken; Enli Liu; Olga Dakhova; Aidin Ashoori; Amanda Corder; Tara Gray; Meng-Fen Wu; Hao Liu; John Hicks; Nino Rainusso; Gianpietro Dotti; Zhuyong Mei; Bambi Grilley; Adrian Gee; Cliona M Rooney; Malcolm K Brenner; Helen E Heslop; Winfried S Wels; Lisa L Wang; Peter Anderson; Stephen Gottschalk
Journal:  J Clin Oncol       Date:  2015-03-23       Impact factor: 44.544

8.  CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.

Authors:  Barbara Savoldo; Carlos Almeida Ramos; Enli Liu; Martha P Mims; Michael J Keating; George Carrum; Rammurti T Kamble; Catherine M Bollard; Adrian P Gee; Zhuyong Mei; Hao Liu; Bambi Grilley; Cliona M Rooney; Helen E Heslop; Malcolm K Brenner; Gianpietro Dotti
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

9.  Inducible apoptosis as a safety switch for adoptive cell therapy.

Authors:  Antonio Di Stasi; Siok-Keen Tey; Gianpietro Dotti; Yuriko Fujita; Alana Kennedy-Nasser; Caridad Martinez; Karin Straathof; Enli Liu; April G Durett; Bambi Grilley; Hao Liu; Conrad R Cruz; Barbara Savoldo; Adrian P Gee; John Schindler; Robert A Krance; Helen E Heslop; David M Spencer; Cliona M Rooney; Malcolm K Brenner
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

10.  HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.

Authors:  Nabil Ahmed; Vita Brawley; Meenakshi Hegde; Kevin Bielamowicz; Mamta Kalra; Daniel Landi; Catherine Robertson; Tara L Gray; Oumar Diouf; Amanda Wakefield; Alexia Ghazi; Claudia Gerken; Zhongzhen Yi; Aidin Ashoori; Meng-Fen Wu; Hao Liu; Cliona Rooney; Gianpietro Dotti; Adrian Gee; Jack Su; Yvonne Kew; David Baskin; Yi Jonathan Zhang; Pamela New; Bambi Grilley; Milica Stojakovic; John Hicks; Suzanne Z Powell; Malcolm K Brenner; Helen E Heslop; Robert Grossman; Winfried S Wels; Stephen Gottschalk
Journal:  JAMA Oncol       Date:  2017-08-01       Impact factor: 31.777

View more
  3 in total

Review 1.  The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19.

Authors:  Peter Braendstrup; Bruce L Levine; Marco Ruella
Journal:  Cytotherapy       Date:  2020-02-01       Impact factor: 5.414

2.  Seek and You Will Not Find: Ending the Hunt for Replication-Competent Retroviruses during Human Gene Therapy.

Authors:  Helen E Heslop; Malcolm K Brenner
Journal:  Mol Ther       Date:  2017-12-20       Impact factor: 11.454

Review 3.  Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy.

Authors:  Cassie K Chou; Cameron J Turtle
Journal:  Expert Opin Biol Ther       Date:  2020-02-24       Impact factor: 4.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.